7:34 am Palatin Technologies presents positive new data analyses demonstrating efficacy of bremelanotide in female hypoactive sexual desire disorder
View todays social media effects on PTN
View the latest stocks trending across Twitter. Click to view dashboard
See who Palatin is hiring next, click here to view
